The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
St. Louis, Missouri: Largest U.S. center of excellence for single-use technology in biologics manufacturing
Video
In 2021, Thermo Fisher Scientific completed an $82.5 million expansion at our biologics site in St. Louis, Missouri, adding two manufacturing suites and $15 million in upgraded equipment, including the DynaDrive™ HyPerforma™ 5,000 L Single-Use Bioreactor (S.U.B.), to support large-scale production. The expansion more than doubled the site’s overall capacity to develop and commercialize specialized treatments for a variety of conditions and rare diseases that compromise the immune system, establishing it as the largest single-use technology (S.U.T.) CDMO facility in the United States.
Watch the video to learn more about the site expansion.
Read about the benefits of S.U.T.—from increased sustainability and reduced costs to accelerated timelines and higher production efficiency—with these helpful resources: